Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 2/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5309684 | 0.78 | ALPL (0.44) | PPARAALPLALPIALPGSSTR4 | |
| SCHEMBL17506734 | 0.76 | CYP3A4 (0.47) | PPARAALOX15PPARGPOLBHPGD | |
| SCHEMBL3465226 | 0.75 | PPARA (0.47) | PPARAALPLALPIALPGSSTR4 | |
| SCHEMBL5724626 | 0.74 | PPARA (0.58) | PPARASSTR4ALOX15PPARG | |
| SCHEMBL7805112 | 0.73 | PPARA (0.49) | PPARAALPLALPIALPGSSTR4 | |
| SCHEMBL14975398 | 0.72 | NPC1 (0.46) | PPARARAB9ANPC1CASP3SENP7 | |
| SCHEMBL2517194 | 0.71 | ALDH1A1 (0.60) | PPARAALPLALPIALPGSSTR4 | |
| SCHEMBL97622 | 0.71 | KCNA3 (0.41) | PPARAALPLALPIALPGSSTR4 | |
| SCHEMBL5266201 | 0.70 | PPARA (0.48) | PPARAALPLALPIALPGSSTR4 | |
| SCHEMBL5367643 | 0.70 | SSTR4 (0.51) | PPARAALPLALPIALPGSSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12011496-B2 | Topical macqui berry formulation | Tracie Martyn International, Inc. (US) | 2024-06-18 | — | — | US | disclosed |
| US-10993897-B2 | Topical macqui berry formula | Tracie Martyn International, Inc. (US) | 2021-05-04 | — | — | US | disclosed |
| US-20190151227-A1 | TOPICAL MACQUI BERRY FORMULA | TRACIE MARTYN INT INC (US) | 2019-05-23 | — | — | US | disclosed |
| US-20170027853-A1 | TOPICAL MACQUI BERRY FORMULATION | TRACIE MARTYN INTERNATIONAL, LLC | 2017-02-02 | — | — | US | disclosed |
| US-9463153-B2 | Topical macqui berry formulation | Trade Martyn International, LLC (US) | 2016-10-11 | — | — | US | disclosed |
| US-20150150770-A1 | METHODS OF TREATING SKIN | TRACIE MARTYN INTERNATIONAL INC (US) | 2015-06-04 | — | — | US | disclosed |
| US-9040553-B2 | Phenoxyisobutyric acid compounds and method of synthesis | Cell Viable Corporation (US) | 2015-05-26 | — | — | US | disclosed |
| US-20140377338-A1 | TOPICAL MACQUI BERRY FORMULATION | TRACIE MARTYN INTERNATIONAL, LLC | 2014-12-25 | — | — | US | disclosed |
| US-20140371316-A1 | DERIVATIVES OF PHENOXYISOBUTYRIC ACID | FABRICANT JILL S (US) | 2014-12-18 | — | — | US | disclosed |
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | LALEZARI IRAJ (US) | 2014-11-27 | — | — | US | disclosed |
| US-20020013256-A1 | Novel inhibitors of formation of advanced glycation endproducts (AGES) | PROSCIENCE CORPORATION, INCORPORATED IN THE STATE OF NEW YORK | 2002-01-31 | — | — | US | disclosed |
| US-6337350-B1 | CROSSLINKING INHIBITION OF PROTEINS | CITY OF HOPE | 2002-01-08 | — | — | US | disclosed |
| US-6337350-B1 | CROSSLINKING INHIBITION OF PROTEINS | CITY OF HOPE | 2002-01-08 | — | — | US | disclosed |
| US-20020002203-A1 | Novel breakers of advanced glycation endproducts | CITY OF HOPE | 2002-01-03 | — | — | US | disclosed |
| EP-1165064-A2 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | City of Hope (US) | 2002-01-02 | — | — | EP | disclosed |
| EP-1165064-A2 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | City of Hope (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001076584-A2 | USE OF BREAKERS OF ADVANCED GLYCATION ENDPRODUCTS FOR TREATING DELETERIOUS EFFECTS OF AGING AND DEBILITATING DISEASES | CITY OF HOPE (US) | 2001-10-18 | — | — | WO | disclosed |
| WO-2000059875-A3 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | HOPE CITY (US) | 2001-03-29 | — | — | WO | disclosed |
| WO-2000059875-A2 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | CITY OF HOPE (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000059875-A2 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | CITY OF HOPE (US) | 2000-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002203-A1 | Novel breakers of advanced glycation endproducts | AGER, SSB, MRPS18B | PPARA 1868/4885ALPL 4660/4885ALPI 4163/4885 |
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | AGER, BPGM, PDXK | PPARA 262/4885ALPL 1930/4885ALPI 719/4885 |
| US-20150150770-A1 | METHODS OF TREATING SKIN | CUTA, LIPA, DLAT | PPARA 192/4885ALPL 1692/4885ALPI 2530/4885 |
| US-20140371316-A1 | DERIVATIVES OF PHENOXYISOBUTYRIC ACID | AGER, BPGM, FOSB | PPARA 287/4885ALPL 3196/4885ALPI 894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.